New York State Teachers Retirement System Decreases Stake in Sabra Healthcare REIT, Inc. $SBRA

New York State Teachers Retirement System lessened its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 9.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 294,008 shares of the real estate investment trust’s stock after selling 30,704 shares during the period. New York State Teachers Retirement System’s holdings in Sabra Healthcare REIT were worth $5,654,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock valued at $472,617,000 after purchasing an additional 4,431,897 shares during the period. Bank of Montreal Can grew its position in Sabra Healthcare REIT by 8.2% during the third quarter. Bank of Montreal Can now owns 2,787,655 shares of the real estate investment trust’s stock worth $51,962,000 after buying an additional 211,686 shares during the period. Legal & General Group Plc grew its position in Sabra Healthcare REIT by 16.5% during the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock worth $27,031,000 after buying an additional 201,667 shares during the period. UBS Group AG increased its holdings in Sabra Healthcare REIT by 143.1% in the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock valued at $27,657,000 after buying an additional 859,584 shares in the last quarter. Finally, Advisors Capital Management LLC lifted its position in shares of Sabra Healthcare REIT by 3.2% during the 4th quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock valued at $45,133,000 after acquiring an additional 73,281 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on SBRA shares. Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Truist Financial boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Cantor Fitzgerald upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. UBS Group set a $19.00 price target on Sabra Healthcare REIT in a research report on Thursday, June 18th. Finally, Scotiabank decreased their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research report on Thursday, June 18th. Five research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $21.27.

Sabra Healthcare REIT Trading Up 1.7%

Shares of Sabra Healthcare REIT stock opened at $20.06 on Wednesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $21.28. The company has a market capitalization of $5.06 billion, a P/E ratio of 31.84, a P/E/G ratio of 1.47 and a beta of 0.65. The business has a 50 day moving average price of $19.70 and a 200 day moving average price of $19.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the prior year, the firm earned $0.37 EPS. Sabra Healthcare REIT’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.